Recent News

• 09 July 2025   Press Release

  Qanatpharma, Zuse Institute Berlin, Enamine, and Proteros biostructures Announce Generative-AI Driven Lead Discovery Collaboration

  Qanatpharma (QP), Zuse Institute Berlin (ZIB), Enamine, and Proteros biostructures today announced the launch of a research collaboration to accelerate the discovery of novel therapeutics targeting cerebral perfusion deficits associated with subarachnoid hemorrhage (SAH). The collaboration focuses on a protein target identified by QP that is involved in regulating cerebrovascular resistance in the brain—a mechanism shown to be compromised in patients with SAH.

• 02 June 2025   News

  New European distributor - Enamine LV SIA

  We are pleased to announce an important update in our operations. From now on, our official distributor in Europe will be Enamine LV SIA. This change is in line with the company’s global expansion policy.
  This new entity will manage shipments across the European Union, the United Kingdom, the Middle East, Asia, and the Pacific regions and provide compound storage and formatting services.

• 26 May 2025   Press Release

  Enamine to Enable Access to Selected Pfizer Reference Compounds to Support the Global Research Community

  Enamine, the leading provider of chemical compounds and drug discovery services, today announced certain reference compounds from Pfizer are now available through Enamine`s marketplace and Enamine`s integration capabilities (i.e. punchout site, hosted catalogs, and API solutions). This allows researchers to explore and purchase from the catalog of selected Pfizer-provided drugs, chemical dormants, investigational compounds, and isotope-labelled molecules with appropriate quality control.